Your browser doesn't support javascript.
loading
Progeria: a paradigm for translational medicine.
Gordon, Leslie B; Rothman, Frank G; López-Otín, Carlos; Misteli, Tom.
Afiliación
  • Gordon LB; Department of Anesthesia, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Pediatrics, Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, RI 02912, USA. Electronic address: leslie_gordon@brown.edu.
  • Rothman FG; Division of Biology and Medicine, Brown University, Providence, RI 02912, USA.
  • López-Otín C; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, 33006 Oviedo, Spain.
  • Misteli T; National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: mistelit@mail.nih.gov.
Cell ; 156(3): 400-7, 2014 Jan 30.
Article en En | MEDLINE | ID: mdl-24485450
ABSTRACT
Rare diseases are powerful windows into biological processes and can serve as models for the development of therapeutic strategies. The progress made on the premature aging disorder Progeria is a shining example of the impact that studies of rare diseases can have.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progeria / Investigación Biomédica Traslacional Límite: Child / Humans Idioma: En Revista: Cell Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progeria / Investigación Biomédica Traslacional Límite: Child / Humans Idioma: En Revista: Cell Año: 2014 Tipo del documento: Article